Insider trades › Johnson & Johnson › Jennifer L Taubert
Jennifer L Taubert: Johnson & Johnson stock transactions
Jennifer L Taubert (EVP, WWC. Innovative Medicine at Johnson & Johnson) reported 2 transactions in JNJ stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Taubert Jennifer L.
$4.0Mopen-market sales (15,000 shares)
$0open-market purchases (0 shares)
2026-08-17most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Aug 17, 2026 | Option or RSU exercise | 15,000 | $115.67 | — | Form 4 ↗ |
| Aug 17, 2026 | Open-market sale | 15,000 | $263.36 | $4.0M | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.